Healthcare
Imperial Innovations leads £13.5m round for Precision Ocular
Consort Medical, NeoMed and Hovione Scientia also joined the funding round
Trilantic Europe invests €66m in Fondazione Maugeri
Trilantic Europe plans to increase its investment in the business to €100m by 2017
MML's Luneau buys French assets of Haag Streit
MML backed French ophthalmology equipment specialist Luneau Technology Group in early 2015
Astorg kickstarts sixth fund with HRA Pharma SBO
Vehicle "likely" to close on €2bn hard-cap before year-end, according to unquote" source
Forbion Capital leads $15m series-B for Akarna
VC backers plan to invest further to reinforce the companyтs growth
VC-backed biotechs sustain faint pulse of Benelux healthcare
Uncertain policies have caused a slow down for healthcare buyouts in Benelux
Seventure in €1m seed round for MilliDrop
Deal saw VC draw on commitments from €60m seed-focused fund Quadrivium I
MIG et al. lead $6m Hemovent series-A
Other investors include WCTI, KfW Bank and more
Permira sells Creganna for $895m
All-cash transaction with TE Connectivity awards Permira a 3.4x return multiple
Sofinnova leads €22m series-A for Enyo Pharma
Round featured €5m contribution from BPI France’s €173m healthcare-focused InnoBio fund
Charme Capital exits Bellco to Medtronic for €110m
GP will concentrate on Charme III fundraising as exit brings Charme II fund to full realisation
Sofinnova and Imperial's Mission Therapeutics raises £60m
Investment led by Woodford Patient Capital Trust and saw existing backers re-up
Mucosis raises €5.7m from BioGeneration et al.
Round comes eight years after €3m injection by BioGeneration and Medsciences, among others
Invitalia Ventures invests €1.5m in Italian startup D-Eye
Italia Venture I fund has announced its first investment in the Italian venture segment
Vasopharm raises €20m from Entrepreneurs Fund et al.
Vasopharm has raised €20m from Entrepreneurs Fund, Heidelberg Capital and other backers
Abingworth closes maiden co-development fund on $105m
VC's 11th vehicle will be used for five to six co-development deals over the next three years
Index backs Morphogen's £1.5m seed round
Index closed its latest fund, Index Ventures Growth III, on тЌ650m in April 2015
Ysios et al. in €11.5m series-A for Aelix
Ysios has backed the HIV vaccine developer via its €100m second healthcare-focused fund
Highlander sells Poland's Medi-system to Orpea
GP exits 50% stake in Polish care provider to Paris-listed trade buyer Orpea
Robert Bosch backs Emperra's $3.1m series-B
Company's series-A reached €2.6m and was led by Peppermint and Goodvent
Advent in £1.5bn Priory Group exit
Advent, which had owned Priory since 2011, will receive a mix of cash and shares
EQT to acquire Ardian's Lima
GP to acquire majority stake via its recently closed €6.75bn seventh buyout fund
VC-backed Acerta sold to trade for up to $7bn
VC backers make partial exit and are set to fully divest in the future
MS Ventures backs Inthera Bioscience's €3.4m round
MS Ventures is the corporate venture capital fund of healthcare business Merck